The Global Network to provide advocacy and resource mobilization support to complement Eisai Co., Ltd.’s historic DEC donation to the World Health Organization (WHO)
March 15, 2011- The Global Network for Neglected Tropical Diseases announced today that it has signed a memorandum of understanding (MOU) with Eisai Co., Ltd to provide advocacy support for Eisai’s diethylcarbamazine (generic name, “DEC”) donation to the World Health Organization (WHO). This donation is a significant contribution to the global neglected tropical disease (NTD) response and will expand the pharmaceutical industry’s role in global health initiatives to combat NTDs. Through collaboration around advocacy activities related to the DEC donation, the Global Network will assist Eisai in forging and maintaining strong ties with international agencies, foundations, corporate and government agencies working to combat NTDs. The Global Network will work with Eisai on its planning, reporting, and implementation activities around the DEC donation and will provide Eisai with technical advice for future decision-making on NTD initiatives. Eisai will work with the Global Network to deepen its engagement in NTD policy, advocacy, and resource mobilization efforts, particularly in Asia.
» Read more: The Global Network for Neglected Tropical Diseases Partners with Eisai Co., Ltd.
